Influenza
Conditions
Interventions
Group Influenza A H1N1:Intravenous peramivir
Group Influenza A H3N2:Intravenous peramivir
Group Influenza B Victoria:Intravenous peramivir
Sponsors
Suqian Hospital of Nanjing Drum Tower Hospital Group
Eligibility
Sex/Gender
All
Age
28 Days to 18 Years
Inclusion criteria
Inclusion criteria: 1. The throat swab of the patient was tested by RT-PCR influenza virus nucleic acid detection kit, and the result was positive for influenza. 2. The children should be over 28 days old and under 18 years old (this project does not include newborns under 28 days old).
Exclusion criteria
Exclusion criteria: 1. Allergic to NA inhibitors; 2. Those who have used antiviral drugs (such as amantadine, rimantadine, oseltamivir, zanamivir, nucleosides, etc.) in the past 1 month; 3. Patients with basic diseases (such as liver and kidney insufficiency, heart insufficiency, nervous system diseases, etc.).
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Time to fever alleviation;Cough to fever alleviation; | — |
Primary
| Measure | Time frame |
|---|---|
| The duration of virus nucleic acid positivity;The remission time of clinical symptoms; | — |
Countries
China
Contacts
Public ContactChen Hongdou
Suqian Hospital of Nanjing Drum Tower Hospital Group
Outcome results
None listed